| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LITHIUM CITRATE | 018421 | 001 | NDA | LITHIUM CITRATE | SYRUP;ORAL | EQ 300MG CARBONATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | 1980/12/23 | Approved Prior to Jan 1, 1982 | HIKMA | Discontinued |
| LITHIUM CITRATE | 070755 | 001 | ANDA | LITHIUM CITRATE | SYRUP;ORAL | EQ 300MG CARBONATE/5ML | No | No | 1986/05/21 | 1986/05/21 | PAI HOLDINGS PHARM | Discontinued |
| LITHIUM CITRATE | 218036 | 001 | ANDA | LITHIUM CITRATE | SYRUP;ORAL | EQ 300MG CARBONATE/5ML | No | Yes | 2023/08/14 | 2023/08/14 | RUBICON | Prescription |
| LITHIUM CITRATE | 217183 | 001 | ANDA | LITHIUM CITRATE | SYRUP;ORAL | EQ 300MG CARBONATE/5ML | No | No | 2024/03/18 | 2024/03/18 | SAPTALIS PHARMS | Prescription |